Compare PNFP & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PNFP | SNN |
|---|---|---|
| Founded | 2000 | 1856 |
| Country | United States | United Kingdom |
| Employees | 3595 | N/A |
| Industry | Major Banks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 14.3B |
| IPO Year | N/A | N/A |
| Metric | PNFP | SNN |
|---|---|---|
| Price | $87.47 | $32.14 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 2 |
| Target Price | ★ $110.87 | $36.25 |
| AVG Volume (30 Days) | ★ 1.2M | 680.0K |
| Earning Date | 04-22-2026 | 04-30-2026 |
| Dividend Yield | 2.29% | ★ 2.34% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $163.66 | $8.61 |
| Revenue Next Year | $7.77 | $5.60 |
| P/E Ratio | ★ $12.24 | $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $81.08 | $23.91 |
| 52 Week High | $120.39 | $38.79 |
| Indicator | PNFP | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 50.76 | 39.60 |
| Support Level | $83.62 | $29.27 |
| Resistance Level | $89.29 | $32.61 |
| Average True Range (ATR) | 2.10 | 0.50 |
| MACD | 0.88 | -0.01 |
| Stochastic Oscillator | 86.76 | 40.04 |
Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.